APO Research

APO RESEARCH · REPORT

Eubiotics

Selected research

Industry Research

Eubiotics Industry Research Report 2026

Market perspective

The global Eubiotics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Eubiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Eubiotics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Eubiotics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Eubiotics include YARA International Asa, SCC Holdings Berhad, Royal DSM, Kemin Industries, DuPont, Chr. Hansen A/S, Cargill Incorporated, Beneo Group and Behn Meyer Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Eubiotics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Eubiotics Market by Company

YARA International Asa

SCC Holdings Berhad

Royal DSM

Kemin Industries

DuPont

Chr. Hansen A/S

Cargill Incorporated

Beneo Group

Behn Meyer Group

BASF SE

Eubiotics Segment by Type

Probiotics

Organic Acid

Eubiotics Segment by Application

Animals

Application 2

Eubiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eubiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Eubiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eubiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Eubiotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Eubiotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Eubiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Eubiotics Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Eubiotics Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Eubiotics Sales Market Share by Manufacturers (2021-2026) Table 8. Global Eubiotics Revenue of Manufacturers (2021-2026) Table 9. Global Eubiotics Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Eubiotics Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Eubiotics Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Eubiotics, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Eubiotics, Product Type & Application Table 14. Global Eubiotics Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Eubiotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. YARA International Asa Company Information Table 19. YARA International Asa Business Overview Table 20. YARA International Asa Eubiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. YARA International Asa Eubiotics Product Portfolio Table 22. YARA International Asa Recent Developments Table 23. SCC Holdings Berhad Company Information Table 24. SCC Holdings Berhad Business Overview Table 25. SCC Holdings Berhad Eubiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. SCC Holdings Berhad Eubiotics Product Portfolio Table 27. SCC Holdings Berhad Recent Developments Table 28. Royal DSM Company Information Table 29. Royal DSM Business Overview Table 30. Royal DSM Eubiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Royal DSM Eubiotics Product Portfolio Table 32. Royal DSM Recent Developments Table 33. Kemin Industries Company Information Table 34. Kemin Industries Business Overview Table 35. Kemin Industries Eubiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Kemin Industries Eubiotics Product Portfolio Table 37. Kemin Industries Recent Developments Table 38. DuPont Company Information Table 39. DuPont Business Overview Table 40. DuPont Eubiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. DuPont Eubiotics Product Portfolio Table 42. DuPont Recent Developments Table 43. Chr. Hansen A/S Company Information Table 44. Chr. Hansen A/S Business Overview Table 45. Chr. Hansen A/S Eubiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Chr. Hansen A/S Eubiotics Product Portfolio Table 47. Chr. Hansen A/S Recent Developments Table 48. Cargill Incorporated Company Information Table 49. Cargill Incorporated Business Overview Table 50. Cargill Incorporated Eubiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Cargill Incorporated Eubiotics Product Portfolio Table 52. Cargill Incorporated Recent Developments Table 53. Beneo Group Company Information Table 54. Beneo Group Business Overview Table 55. Beneo Group Eubiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Beneo Group Eubiotics Product Portfolio Table 57. Beneo Group Recent Developments Table 58. Behn Meyer Group Company Information Table 59. Behn Meyer Group Business Overview Table 60. Behn Meyer Group Eubiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Behn Meyer Group Eubiotics Product Portfolio Table 62. Behn Meyer Group Recent Developments Table 63. BASF SE Company Information Table 64. BASF SE Business Overview Table 65. BASF SE Eubiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. BASF SE Eubiotics Product Portfolio Table 67. BASF SE Recent Developments Table 68. Global Eubiotics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global Eubiotics Sales by Region (2021-2026) & (K Units) Table 70. Global Eubiotics Sales Market Share by Region (2021-2026) Table 71. Global Eubiotics Sales by Region (2027-2032) & (K Units) Table 72. Global Eubiotics Sales Market Share by Region (2027-2032) Table 73. Global Eubiotics Revenue by Region (2021-2026) & (US$ Million) Table 74. Global Eubiotics Revenue Market Share by Region (2021-2026) Table 75. Global Eubiotics Revenue by Region (2027-2032) & (US$ Million) Table 76. Global Eubiotics Revenue Market Share by Region (2027-2032) Table 77. North America Eubiotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America Eubiotics Sales by Country (2021-2026) & (K Units) Table 79. North America Eubiotics Sales by Country (2027-2032) & (K Units) Table 80. North America Eubiotics Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Eubiotics Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe Eubiotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe Eubiotics Sales by Country (2021-2026) & (K Units) Table 84. Europe Eubiotics Sales by Country (2027-2032) & (K Units) Table 85. Europe Eubiotics Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Eubiotics Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific Eubiotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific Eubiotics Sales by Country (2021-2026) & (K Units) Table 89. Asia Pacific Eubiotics Sales by Country (2027-2032) & (K Units) Table 90. Asia Pacific Eubiotics Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific Eubiotics Revenue by Country (2027-2032) & (US$ Million) Table 92. South America Eubiotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America Eubiotics Sales by Country (2021-2026) & (K Units) Table 94. South America Eubiotics Sales by Country (2027-2032) & (K Units) Table 95. South America Eubiotics Revenue by Country (2021-2026) & (US$ Million) Table 96. South America Eubiotics Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa Eubiotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa Eubiotics Sales by Country (2021-2026) & (K Units) Table 99. Middle East and Africa Eubiotics Sales by Country (2027-2032) & (K Units) Table 100. Middle East and Africa Eubiotics Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa Eubiotics Revenue by Country (2027-2032) & (US$ Million) Table 102. Global Eubiotics Sales by Type (2021-2026) & (K Units) Table 103. Global Eubiotics Sales by Type (2027-2032) & (K Units) Table 104. Global Eubiotics Sales Market Share by Type (2021-2026) Table 105. Global Eubiotics Sales Market Share by Type (2027-2032) Table 106. Global Eubiotics Revenue by Type (2021-2026) & (US$ Million) Table 107. Global Eubiotics Revenue by Type (2027-2032) & (US$ Million) Table 108. Global Eubiotics Revenue Market Share by Type (2021-2026) Table 109. Global Eubiotics Revenue Market Share by Type (2027-2032) Table 110. Global Eubiotics Price by Type (2021-2026) & (US$/Unit) Table 111. Global Eubiotics Price by Type (2027-2032) & (US$/Unit) Table 112. Global Eubiotics Sales by Application (2021-2026) & (K Units) Table 113. Global Eubiotics Sales by Application (2027-2032) & (K Units) Table 114. Global Eubiotics Sales Market Share by Application (2021-2026) Table 115. Global Eubiotics Sales Market Share by Application (2027-2032) Table 116. Global Eubiotics Revenue by Application (2021-2026) & (US$ Million) Table 117. Global Eubiotics Revenue by Application (2027-2032) & (US$ Million) Table 118. Global Eubiotics Revenue Market Share by Application (2021-2026) Table 119. Global Eubiotics Revenue Market Share by Application (2027-2032) Table 120. Global Eubiotics Price by Application (2021-2026) & (US$/Unit) Table 121. Global Eubiotics Price by Application (2027-2032) & (US$/Unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Eubiotics Distributors List Table 125. Eubiotics Customers List Table 126. Eubiotics Industry Trends Table 127. Eubiotics Industry Drivers Table 128. Eubiotics Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Eubiotics Product Image Figure 5. Global Eubiotics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Eubiotics Market Size (2021-2032) & (US$ Million) Figure 7. Global Eubiotics Sales (2021-2032) & (K Units) Figure 8. Global Eubiotics Average Price (US$/Unit) & (2021-2032) Figure 9. Probiotics Product Image Figure 10. Organic Acid Product Image Figure 11. Animals Product Image Figure 12. Application 2 Product Image Figure 13. Global Eubiotics Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Eubiotics, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Eubiotics Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Eubiotics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Eubiotics Sales by Region in 2025 Figure 19. Global Eubiotics Revenue by Region in 2025 Figure 20. North America Eubiotics Market Size by Country in 2025 Figure 21. North America Eubiotics Sales Market Share by Country (2021-2032) Figure 22. North America Eubiotics Revenue Market Share by Country (2021-2032) Figure 23. United States Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Eubiotics Market Size by Country in 2025 Figure 27. Europe Eubiotics Sales Market Share by Country (2021-2032) Figure 28. Europe Eubiotics Revenue Market Share by Country (2021-2032) Figure 29. Germany Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Eubiotics Market Size by Country in 2025 Figure 40. Asia Pacific Eubiotics Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Eubiotics Revenue Market Share by Country (2021-2032) Figure 42. China Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Eubiotics Market Size by Country in 2025 Figure 51. South America Eubiotics Sales Market Share by Country (2021-2032) Figure 52. South America Eubiotics Revenue Market Share by Country (2021-2032) Figure 53. Brazil Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Eubiotics Market Size by Country in 2025 Figure 57. Middle East and Africa Eubiotics Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Eubiotics Revenue Market Share by Country (2021-2032) Figure 59. Egypt Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Eubiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Eubiotics Sales Market Share by Type (2021-2032) Figure 65. Global Eubiotics Revenue Market Share by Type (2021-2032) Figure 66. Global Eubiotics Price (US$/Unit) by Type (2021-2032) Figure 67. Global Eubiotics Sales Market Share by Application (2021-2032) Figure 68. Global Eubiotics Revenue Market Share by Application (2021-2032) Figure 69. Global Eubiotics Price (US$/Unit) by Application (2021-2032) Figure 70. Eubiotics Value Chain Figure 71. Eubiotics Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Eubiotics Industry Opportunities and Challenges

Scope & coverage.

Types
  • Probiotics
  • Organic Acid
Applications
  • Animals
  • Application 2
Companies covered
  • YARA International Asa
  • SCC Holdings Berhad
  • Royal DSM
  • Kemin Industries
  • DuPont
  • Chr. Hansen A/S
  • Cargill Incorporated
  • Beneo Group
  • Behn Meyer Group
  • BASF SE

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Eubiotics Market Size (2021-2032)
  4. 2.2.2 Global Eubiotics Sales (2021-2032)
  5. 2.2.3 Global Eubiotics Market Average Price (2021-2032)
  6. 2.3 Eubiotics by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Probiotics
  9. 2.3.3 Organic Acid
  10. 2.4 Eubiotics by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Animals
  13. 2.4.3 Application 2
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Eubiotics Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Eubiotics Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Eubiotics Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Eubiotics Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Eubiotics Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Eubiotics, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Eubiotics, Product Type & Application
  8. 3.8 Global Manufacturers of Eubiotics, Established Date
  9. 3.9 Global Eubiotics Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 YARA International Asa
  2. 4.1.1 YARA International Asa Company Information
  3. 4.1.2 YARA International Asa Business Overview
  4. 4.1.3 YARA International Asa Eubiotics Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 YARA International Asa Eubiotics Product Portfolio
  6. 4.1.5 YARA International Asa Recent Developments
  7. 4.2 SCC Holdings Berhad
  8. 4.2.1 SCC Holdings Berhad Company Information
  9. 4.2.2 SCC Holdings Berhad Business Overview
  10. 4.2.3 SCC Holdings Berhad Eubiotics Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 SCC Holdings Berhad Eubiotics Product Portfolio
  12. 4.2.5 SCC Holdings Berhad Recent Developments
  13. 4.3 Royal DSM
  14. 4.3.1 Royal DSM Company Information
  15. 4.3.2 Royal DSM Business Overview
  16. 4.3.3 Royal DSM Eubiotics Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Royal DSM Eubiotics Product Portfolio
  18. 4.3.5 Royal DSM Recent Developments
  19. 4.4 Kemin Industries
  20. 4.4.1 Kemin Industries Company Information
  21. 4.4.2 Kemin Industries Business Overview
  22. 4.4.3 Kemin Industries Eubiotics Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Kemin Industries Eubiotics Product Portfolio
  24. 4.4.5 Kemin Industries Recent Developments
  25. 4.5 DuPont
  26. 4.5.1 DuPont Company Information
  27. 4.5.2 DuPont Business Overview
  28. 4.5.3 DuPont Eubiotics Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 DuPont Eubiotics Product Portfolio
  30. 4.5.5 DuPont Recent Developments
  31. 4.6 Chr. Hansen A/S
  32. 4.6.1 Chr. Hansen A/S Company Information
  33. 4.6.2 Chr. Hansen A/S Business Overview
  34. 4.6.3 Chr. Hansen A/S Eubiotics Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Chr. Hansen A/S Eubiotics Product Portfolio
  36. 4.6.5 Chr. Hansen A/S Recent Developments
  37. 4.7 Cargill Incorporated
  38. 4.7.1 Cargill Incorporated Company Information
  39. 4.7.2 Cargill Incorporated Business Overview
  40. 4.7.3 Cargill Incorporated Eubiotics Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Cargill Incorporated Eubiotics Product Portfolio
  42. 4.7.5 Cargill Incorporated Recent Developments
  43. 4.8 Beneo Group
  44. 4.8.1 Beneo Group Company Information
  45. 4.8.2 Beneo Group Business Overview
  46. 4.8.3 Beneo Group Eubiotics Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Beneo Group Eubiotics Product Portfolio
  48. 4.8.5 Beneo Group Recent Developments
  49. 4.9 Behn Meyer Group
  50. 4.9.1 Behn Meyer Group Company Information
  51. 4.9.2 Behn Meyer Group Business Overview
  52. 4.9.3 Behn Meyer Group Eubiotics Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Behn Meyer Group Eubiotics Product Portfolio
  54. 4.9.5 Behn Meyer Group Recent Developments
  55. 4.10 BASF SE
  56. 4.10.1 BASF SE Company Information
  57. 4.10.2 BASF SE Business Overview
  58. 4.10.3 BASF SE Eubiotics Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 BASF SE Eubiotics Product Portfolio
  60. 4.10.5 BASF SE Recent Developments
5 Global Eubiotics Market Scenario by Region
  1. 5.1 Global Eubiotics Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Eubiotics Sales by Region: 2021-2032
  3. 5.2.1 Global Eubiotics Sales by Region: 2021-2026
  4. 5.2.2 Global Eubiotics Sales by Region: 2027-2032
  5. 5.3 Global Eubiotics Revenue by Region: 2021-2032
  6. 5.3.1 Global Eubiotics Revenue by Region: 2021-2026
  7. 5.3.2 Global Eubiotics Revenue by Region: 2027-2032
  8. 5.4 North America Eubiotics Market Facts & Figures by Country
  9. 5.4.1 North America Eubiotics Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Eubiotics Sales by Country (2021-2032)
  11. 5.4.3 North America Eubiotics Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Eubiotics Market Facts & Figures by Country
  16. 5.5.1 Europe Eubiotics Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Eubiotics Sales by Country (2021-2032)
  18. 5.5.3 Europe Eubiotics Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Eubiotics Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Eubiotics Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Eubiotics Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Eubiotics Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Eubiotics Market Facts & Figures by Country
  41. 5.7.1 South America Eubiotics Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Eubiotics Sales by Country (2021-2032)
  43. 5.7.3 South America Eubiotics Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Eubiotics Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Eubiotics Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Eubiotics Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Eubiotics Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Eubiotics Sales by Type (2021-2032)
  2. 6.1.1 Global Eubiotics Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Eubiotics Sales Market Share by Type (2021-2032)
  4. 6.2 Global Eubiotics Revenue by Type (2021-2032)
  5. 6.2.1 Global Eubiotics Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Eubiotics Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Eubiotics Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Eubiotics Sales by Application (2021-2032)
  2. 7.1.1 Global Eubiotics Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Eubiotics Sales Market Share by Application (2021-2032)
  4. 7.2 Global Eubiotics Revenue by Application (2021-2032)
  5. 7.2.1 Global Eubiotics Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Eubiotics Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Eubiotics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Eubiotics Value Chain Analysis
  2. 8.1.1 Eubiotics Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Eubiotics Production Mode & Process
  5. 8.2 Eubiotics Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Eubiotics Distributors
  8. 8.2.3 Eubiotics Customers
9 Global Eubiotics Analyzing Market Dynamics
  1. 9.1 Eubiotics Industry Trends
  2. 9.2 Eubiotics Industry Drivers
  3. 9.3 Eubiotics Industry Opportunities and Challenges
  4. 9.4 Eubiotics Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research